Why you should include binding kinetics in drug discovery

Date Dec 13, 2018
Time 4pm CET/GMT+1
Cost Free
Online
In this webinar Prof. Ana Corrionero discusses the importance of binding kinetics:
·       How an early evaluation of the kinetics of drug-target interactions leads to a better selection of interesting compounds to be further profiled.
·       Binding kinetics allows you to choose the most efficient compounds and with the best safety profile.
·       Why kinetic selectivity profiling is a powerful tool to achieve the desired selectivity profile.
·       She will also present research on the kinetic profile of several kinase inhibitors approved by the FDA or in clinical trials against various kinases.

 


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list